Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Recombinant Human Interleukin-2 for Injection

Approval Number

国药准字S10970018

Company北京四环生物制药有限公司

Registration Date

August 13, 2020

Previous Approval Numbers

国药准字S10970018

Drug Information

Generic Name

注射用人白介素-2

Trade Name

德路生

Brand Name

德路生

Dosage Form

注射剂

Strength

10万IU/0.60ml/瓶

Drug Type

生物制品

Registration Date

August 13, 2020

Company Information

Applicant Company

Company Name北京四环生物制药有限公司

Company Address

北京市北京经济技术开发区建安街5号

Manufacturing Company

Company Name北京四环生物制药有限公司

Company Address

北京市北京经济技术开发区建安街5号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy